Intravascular Ultrasound [IVUS] Devices Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Market Size (2025) | USD 1.12 Billion |
| Market Size (2030) | USD 1.59 Billion |
| Growth Rate (2025 - 2030) | 6.80% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players![Major players in Intravascular Ultrasound [IVUS] Devices industry](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-1755589766676-major-players.webp)
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
![Intravascular Ultrasound [IVUS] Devices Market (2025 - 2030)](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-size-image-1755589302716.webp)
Intravascular Ultrasound [IVUS] Devices Market Analysis by Mordor Intelligence
The global IVUS market size reached USD 1.12 billion in 2025 and is on track to climb to USD 1.59 billion by 2030, translating into a robust 6.8% CAGR over the forecast period. North America dominates current revenues, yet Asia Pacific is expanding fastest as the regional cardiovascular disease burden rises faster than any other geography. Catheters remain the volume backbone of IVUS procedures, but accessories are outpacing with double-digit growth, pointing to infrastructure build-out and workflow upgrades. Peripheral vascular interventions now register the highest application-level CAGR, underlining the shift from coronary-only imaging toward broader vascular care. Finally, Class 1A U.S. guideline endorsements for IVUS have firmly validated the modality, accelerating capital-purchase decisions despite lingering cost concerns.
Key Report Takeaways
- By product category, catheters held a 62.3% IVUS market share in 2024, while accessories are projected to post an 11.8% CAGR through 2030.
- By application, coronary interventions accounted for 48.2% of the IVUS market size in 2024, yet peripheral interventions are advancing at a 12.9% CAGR through 2030.
- By end user, hospitals captured 54.9% revenue share of the IVUS market in 2024, whereas ambulatory surgical centers are growing fastest at 10.6% CAGR to 2030.
- By geography, North America accounted for 45.8% of the market size in 2024, and the Asia Pacific is anticipated to record the fastest 8.7% CAGR up to 2030.
Global Intravascular Ultrasound [IVUS] Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Escalating global cardiovascular disease burden | +1.80% | Worldwide, APAC highest | Long term (≥ 4 years) |
| Shift toward minimally-invasive, image-guided PCI | +1.20% | North America & EU lead | Medium term (2-4 years) |
| Catheter miniaturization & higher-frequency transducers | +0.90% | U.S., Japan, China | Short term (≤ 2 years) |
| Reimbursement expansion for IVUS-guided stenting | +0.80% | OECD markets | Medium term (2-4 years) |
| AI-enabled real-time plaque analytics | +0.70% | North America & EU | Short term (≤ 2 years) |
| Commercial roll-out of hybrid IVUS-OCT consoles | +0.60% | Developed markets | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Escalating Global Cardiovascular Disease Burden
Ischemic heart disease prevalence reached 367.21 cases per 100,000 worldwide in 2024 and continues to rise, with Asia Pacific mortality projected to jump 91.2% by 2050.[1]Rachel Sze Jen Goh et al., “The burden of cardiovascular disease in Asia from 2025 to 2050,” The Lancet Regional Health – Western Pacific, thelancet.com Health systems therefore prioritize precision imaging that lowers target-vessel failure by 46% compared with angiography alone. Aging populations in North America and Western Europe further amplify demand for IVUS-guided complex multivessel procedures, underpinning long-run IVUS market growth.
Growing Shift Toward Minimally-Invasive & Image-Guided PCI
Randomized studies show IVUS-guided PCI achieves 83.8% primary patency versus 70.1% under angiography guidance for peripheral artery disease.[2]American College of Cardiology, “Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment,” acc.org AI-powered systems such as AVVIGO shorten workflow and elevate accuracy, further institutionalizing image-guided standards. FDA clearances for next-generation consoles reinforce confidence among providers and payers alike.
Rapid Catheter Miniaturization & Higher-Frequency Transducers
Sixty-megahertz transducers resolve plaque morphology invisible to 40 MHz systems, while dual-frequency probes push axial resolution to 17 µm. Miniaturized 4 Fr-compatible catheters reduce access complications and open smaller vessels, extending the IVUS market addressable pool.
Reimbursement Expansion for IVUS-Guided Stenting in OECD Markets
Australia’s new Medicare item 38325 reimburses IVUS-guided stent insertion, removing historical financial hurdles.[3]Australian Government Department of Health, “Intravascular ultrasound guided coronary stent insertion – New item,” mbsonline.gov.au Cost-saving analyses show USD 18,173 per-patient savings in peripheral interventions when IVUS is employed. Increasing coverage in other OECD countries fuels procedure volumes and console demand.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Capital cost of consoles & single-use catheters | -1.40% | Global, emerging markets hit hardest | Medium term (2-4 years) |
| Shortage of IVUS-trained interventional cardiologists | -0.90% | Worldwide, APAC acute | Long term (≥ 4 years) |
| Photo-acoustic IVI systems winning early grants | -0.60% | U.S. & EU research hubs | Long term (≥ 4 years) |
| Limited long-term outcome data in peripheral interventions | -0.50% | Evidence-driven markets | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Capital Cost of Consoles & Single-Use Catheter Pricing
Console acquisition often exceeds USD 200,000, while disposable catheters cost USD 800–1,500 each, creating steep up-front and recurring expenses for cost-constrained facilities. Reprocessed catheters offer partial relief but carry regulatory hurdles.
Shortage of IVUS-Trained Interventional Cardiologists
Only 15% of trainees feel competent in IVUS interpretation, slowing adoption. Although manufacturers sponsor fellowship programs, global scale-up remains incremental.
Segment Analysis
By Product Type: Catheters Drive Volume, Accessories Accelerate Growth
Catheters retained a commanding 62.3% IVUS market share in 2024, anchored by their indispensable role during every procedure. Accessories are registering a 11.8% CAGR in 2030, reflecting investment in guidewires, sheaths, and data-integration modules that streamline workflows. Next-generation designs, such as Philips’ Visions PV.035 catheter capable of imaging vessels up to 60 mm, illustrate how manufacturers capture additional value while keeping catheters at the core.
Console sales grow steadily as replacement cycles and software upgrades refresh installed bases. FDA recognition of reprocessed catheters suggests cost-focused institutions may rebalance purchasing decisions, yet premium centers continue to favor single-use, higher-frequency devices. Collectively, these dynamics bolster the IVUS market, even as price competition tempers average selling prices for mature catheter SKUs.
![Intravascular Ultrasound [IVUS] Devices Market: Market Share by Product Type](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-Intravascular-Ultrasound-IVUS-Devices-Market-Market-Share-by-Product-Type-2024-1755674492967.webp)
Note: Segment shares of all individual segments available upon report purchase
By Application: Coronary Dominance Meets Peripheral Acceleration
Coronary interventions produced 48.2% of the IVUS market size in 2024, benefitting from three decades of clinical evidence and established reimbursement. Peripheral interventions, however, are expanding at a 12.9% CAGR as multidisciplinary societies endorse IVUS to navigate calcified, long-segment lesions.
Emerging diagnostic use cases leverage AI-driven plaque composition analytics for risk stratification. Research labs employ IVUS to validate device efficacy, further integrating the modality into trial protocols. Collectively, widening applications reinforce the diversity of revenue streams underpinning the IVUS market.
By End User: Hospital Stability Contrasts ASC Dynamism
Hospitals owned 54.9% of the IVUS market revenue in 2024 and remain the default venue for high-complexity cases. Ambulatory surgical centers are scaling at a 10.6% CAGR as reimbursement equalizes and minimally invasive procedures migrate to outpatient settings.
Specialty imaging centers and mobile catheterization units fall into the “Others” bucket, targeting underserved regions and overflow demand. Their rise highlights how diversified care settings collectively expand the IVUS market footprint.
![Intravascular Ultrasound [IVUS] Devices Market: Market Share by End User](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-Intravascular-Ultrasound-IVUS-Devices-Market-Market-Share-by-End-User-2024-1755674540049.webp)
Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
North America delivered 45.8% of IVUS market revenue in 2024, buoyed by Medicare-backed payment certainty, deep cath-lab penetration, and a steady cadence of FDA clearances for hybrid and AI-enabled systems. Academic networks in the United States champion early adoption of high-frequency catheters, while Canadian provinces invest in provincial cardiovascular initiatives. Mexico, though smaller, is layering IVUS into modernization plans alongside rising PCI volumes.
Europe posts solid growth as ESC guidelines reinforce intracoronary imaging for complex lesions. Germany and the United Kingdom spearhead console installations, supported by well-funded university hospitals. Harmonized CE-mark pathways accelerate time-to-market for new catheters, sustaining competitive churn and keeping the IVUS market dynamic across the continent.
Asia Pacific is the fastest-growing geography with an 8.7% CAGR forecast. China’s steep rise in cardiovascular mortality is mobilizing public hospitals to purchase IVUS consoles, making the country the single largest incremental revenue contributor within the IVUS market. Japan advances transducer innovation, while India’s expanding insurance coverage and medical tourism funnel procedures to high-volume private centers. Australia’s new reimbursement item further greases adoption, and the broader region benefits from urbanization and rising disposable incomes.
![Intravascular Ultrasound [IVUS] Devices Market CAGR (%), Growth Rate by Region](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-Intravascular-Ultrasound-IVUS-Devices-Market-CAGR--Growth-Rate-by-Region-2025---2030-1755674585745.webp)
Competitive Landscape
The IVUS market shows moderate concentration, with Boston Scientific, Abbott, and Philips collectively controlling a meaningful revenue share, each coupling hardware with proprietary AI software. Boston Scientific’s AVVIGO and Abbott’s complementary physiology tools illustrate vertical integration strategies, locking customers into end-to-end ecosystems.
Mid-tier innovators pursue differentiation through hybrid imaging. Conavi Medical’s Novasight-powered IVUS-OCT catheter has gained momentum following Class 1A U.S. guideline status, signaling that multi-modality is no longer experimental but mainstream. Siemens Healthineers and Vivolight Medical are taking a similar tack by integrating DSA-OCT suites into cath-lab architecture, underscoring how cross-platform imaging is reshaping competitive vectors.
Emergent photo-acoustic systems have secured early research grants that could eventually disrupt incumbent ultrasound platforms by delivering superior plaque composition insights. Yet commercialization remains several years away, giving current IVUS players time to iterate. Manufacturer-sponsored training programs aim to plug the operator-skill gap, cement vendor-provider relationships, and fortify long-run positions within the IVUS industry.
Intravascular Ultrasound [IVUS] Devices Industry Leaders
-
Koninklijke Philips N.V.
-
Boston Scientific Corporation
-
Terumo Corporation
-
Canon Medical Systems Corporation
-
Conavi Medical Inc.
- *Disclaimer: Major Players sorted in no particular order
![Intravascular Ultrasound [IVUS] Devices Market](https://s3.mordorintelligence.com/intravascular-ultrasound-ivus-devices-market/intravascular-ultrasound-ivus-devices-market-competitive-landscape-1755596488073.webp)
Recent Industry Developments
- February 2025: Canon Healthcare USA purchased a facility in Cleveland’s Innovation District that will serve as both its U.S. headquarters and an imaging R&D hub. The site is intended to fast-track work on next-generation ultrasound systems, including intravascular platforms, and to foster joint projects with the Cleveland Clinic and other regional partners.
- January 2025: Conavi Medical broadened the commercial reach of its Novasight hybrid IVUS-OCT system by partnering with Minnetronix and closing a new funding round. With FDA and China NMPA approvals in hand and the PANOVISION trial underway, the company aims to scale its multi-modality platform across key global markets.
- September 2024: SpectraWAVE secured USD 50 million in Series B financing, led by Johnson & Johnson Innovation, to accelerate HyperVue—an intravascular ultrasound platform that layers AI-driven plaque-analysis software onto its imaging catheter. The fresh capital underscores investor confidence in real-time decision-support tools that pair IVUS hardware with advanced analytics.
Global Intravascular Ultrasound [IVUS] Devices Market Report Scope
| IVUS Consoles |
| IVUS Catheters |
| IVUS Accessories (Guidewires, Sheaths, Others) |
| Coronary Diagnostics |
| Coronary Interventions |
| Peripheral Vascular Diagnostics |
| Peripheral Interventions |
| Research & Clinical Trials |
| Hospitals |
| Ambulatory Surgical Centers (ASCs) |
| Cardiac Catheterization Labs |
| Diagnostic Imaging Centers |
| Others |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Australia | |
| Rest of Asia Pacific | |
| Middle East & Africa | GCC |
| South Africa | |
| Rest of Middle East & Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product Type | IVUS Consoles | |
| IVUS Catheters | ||
| IVUS Accessories (Guidewires, Sheaths, Others) | ||
| By Application | Coronary Diagnostics | |
| Coronary Interventions | ||
| Peripheral Vascular Diagnostics | ||
| Peripheral Interventions | ||
| Research & Clinical Trials | ||
| By End User | Hospitals | |
| Ambulatory Surgical Centers (ASCs) | ||
| Cardiac Catheterization Labs | ||
| Diagnostic Imaging Centers | ||
| Others | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Australia | ||
| Rest of Asia Pacific | ||
| Middle East & Africa | GCC | |
| South Africa | ||
| Rest of Middle East & Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
What is the current global value of the IVUS market?
The IVUS market size reached USD 1.12 billion in 2025 and is forecast to hit USD 1.59 billion by 2030.
Which region will expand fastest through 2030?
Asia Pacific is projected to grow at an 8.7% CAGR on the back of rising cardiovascular disease prevalence and improving reimbursement.
Which product category leads IVUS procedure revenues?
Catheters command 62.3% of the IVUS market share and will continue to generate the bulk of procedural revenue.
Why are ambulatory surgical centers important for IVUS adoption?
ASCs are the fastest-growing end-user group with a 10.6% CAGR, benefiting from outpatient procedure migration and cost-effective care models.
How do reimbursement changes influence IVUS uptake?
Direct payment codes, such as Australias Medicare item 38325, remove financial barriers and significantly boost procedure volumes.
What technological trend most differentiates new IVUS systems?
Hybrid IVUS-OCT consoles and AI-driven plaque analytics provide clinicians simultaneous multi-modality insight and automated measurements, enhancing decision quality and efficiency.
Page last updated on:
